A Friday, March 2, 2012 photo shows the exterior of Pfizer in Groton, Conn. Pfizer Inc. Shares of Pfizer Inc. and Bristol-Myers Squibb Co. fell Monday, June 25, 2012, after federal regulators unexpectedly delayed for a second time a decision on whether to approve the companies' highly touted experimental anticlotting drug Eliquis. (AP Photo/Elise Amendola)

Associated Press
A Friday, March 2, 2012 photo shows the exterior of Pfizer in Groton, Conn. Pfizer Inc. Shares of Pfizer Inc. and Bristol-Myers Squibb Co. fell Monday, June 25, 2012, after federal regulators unexpectedly delayed for a second time a decision on whether to approve the companies' highly touted experimental anticlotting drug Eliquis.  (AP Photo/Elise Amendola)
A Friday, March 2, 2012 photo shows the exterior of Pfizer in Groton, Conn. Pfizer Inc. Shares of Pfizer Inc. and Bristol-Myers Squibb Co. fell Monday, June 25, 2012, after federal regulators unexpectedly delayed for a second time a decision on whether to approve the companies' highly touted experimental anticlotting drug Eliquis. (AP Photo/Elise Amendola)
View Comments (0)